Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Givosiran in acute intermittent porphyria: A personalized medicine approach
Antoine Poli, Caroline Schmitt, Boualem Moulouel, et al.
Molecular Genetics and Metabolism (2022) Vol. 135, Iss. 3, pp. 206-214
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
Bruce Wang, Herbert L. Bonkovsky, Joseph K. Lim, et al.
Gastroenterology (2023) Vol. 164, Iss. 3, pp. 484-491
Open Access | Times Cited: 36
Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy
Chaudry Nasir Majeed, D. Christopher, Ted Xiao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1827-1845
Open Access | Times Cited: 25
Report on the 6th Ottawa International Conference on Neuromuscular Disease & Biology – September 7–9, 2023, Ottawa, Canada
Jodi Warman‐Chardon, Bernard J. Jasmin, Rashmi Kothary, et al.
Journal of Neuromuscular Diseases (2025) Vol. 12, Iss. 1
Closed Access
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran
Paolo Ventura, Eliane Sardh, Nicola Longo, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 9, pp. 879-894
Open Access | Times Cited: 20
Crab-shaped DNA tetrahedral nanomachine for silencing undruggable mRNA targets in prostate cancer
Fangning Wan, Zheng Liu, Junyu Zhang, et al.
Nano Today (2024) Vol. 55, pp. 102187-102187
Open Access | Times Cited: 4
Liver transplantation and primary liver cancer in porphyria
Mattias Lissing, Bruce Wang, Staffan Wåhlin
Liver International (2024)
Open Access | Times Cited: 4
Exploring current and emerging therapies for porphyrias
Daniel Jericó, Karol M. Córdoba, F Urigo, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2174-2190
Closed Access | Times Cited: 4
Case‐based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management
Manisha Balwani, Sioḃán Keel, Peter N. Meissner, et al.
Liver International (2024)
Open Access | Times Cited: 3
Pain in acute hepatic porphyrias: Updates on pathophysiology and management
Mohamed Kazamel, Elena Pischik, Robert J. Desnick
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 14
Personalized dosage of Givosiran in acute intermittent porphyria
Manuel Garrido Montes, R Mataix, José Salvador García Morillo
Medicina Clínica (2024) Vol. 163, Iss. 5, pp. 260-261
Closed Access | Times Cited: 2
RNA interference therapy in acute hepatic porphyrias
Makiko Yasuda, Sioḃán Keel, Manisha Balwani
Blood (2023) Vol. 142, Iss. 19, pp. 1589-1599
Open Access | Times Cited: 6
RNA solutions to treat inborn errors of metabolism
Ainhoa Martínez‐Pizarro, Lourdes R. Desviat
Molecular Genetics and Metabolism (2022) Vol. 136, Iss. 4, pp. 289-295
Open Access | Times Cited: 9
Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know
Petro E. Petrides
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1618-1618
Open Access | Times Cited: 8
Long‐term complications in acute porphyria
Elena Pischik, Mattias Lissing, Nicolas Pallet, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2197-2207
Closed Access | Times Cited: 1
Personalized pharmacological prophylaxis of acute intermittent porphyria: The need for objective biochemical markers
Hung‐Chou Kuo
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. e244-e246
Closed Access | Times Cited: 1
Bioanalytical approaches to support the development of antibody-oligonucleotide conjugate (AOC) therapeutic proteins
Anthony T. Murphy, Ryan C. Hill, Michael J. Berna
Xenobiotica (2024) Vol. 54, Iss. 8, pp. 552-562
Closed Access | Times Cited: 1
Acute hepatic porphyrias – a guide for Hepatologists
Akshata Moghe, Brendan M. McGuire, Cynthia Levy
Hepatology (2024)
Closed Access | Times Cited: 1
German Real-World Experience of Patients with Diverse Features of Acute Intermittent Porphyria Treated with Givosiran
Ilja Kubisch, Nils Wohmann, Thaddäus Till Wissniowski, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6779-6779
Open Access | Times Cited: 1
Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria
D. Christopher, Denise Faust, Herbert L. Bonkovsky
Molecular Genetics and Metabolism Reports (2022) Vol. 34, pp. 100946-100946
Open Access | Times Cited: 7
Quantification of Urine and Plasma Porphyrin Precursors Using LC–MS in Acute Hepatic Porphyrias: Improvement in Routine Diagnosis and in the Monitoring of Kidney Failure Patients
Antoine Poli, Hana Manceau, Anvi Laëtitia Nguyen, et al.
Clinical Chemistry (2023) Vol. 69, Iss. 10, pp. 1186-1196
Open Access | Times Cited: 3
Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis
Hung‐Chou Kuo, Long‐Sun Ro, Chia‐Ni Lin, et al.
Hepatology Communications (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 3
Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function
Marthe S. Christie, Mikko Laitaoja, Aasne K. Aarsand, et al.
FEBS Open Bio (2022) Vol. 12, Iss. 12, pp. 2136-2146
Open Access | Times Cited: 4
Preventing hyperhomocysteinemia using vitamin B6 supplementation in Givosiran-treated acute intermittent porphyria: Highlights from a case report and brief literature review
Isabelle Redonnet‐Vernhet, P. Mercié, Louis Lebreton, et al.
Molecular Genetics and Metabolism Reports (2024) Vol. 39, pp. 101076-101076
Open Access
Effectiveness and tolerability of givosiran for the management of acute hepatic porphyria: A monocenter real-life evaluation
Claudio Carmine Guida, Maria Nardella, Aurora Del Mar Ys Perez, et al.
Molecular Genetics and Metabolism Reports (2024) Vol. 40, pp. 101111-101111
Open Access
Givosiran for the Treatment of Pediatric Acute Intermittent Porphyria
Kenneth E. Bujold, Nicole Kasher, Christine McKiernan
Journal of Pediatric Hematology/Oncology (2024) Vol. 46, Iss. 7, pp. e524-e527
Open Access
Page 1 - Next Page

Scroll to top